Menu
Sign In Pricing Add Podcast

BackTable Urology

Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo

937.486 - 961.196 Dr. Andrea Apolo

Yeah, and I think we need to understand that when the patients are getting combination therapy, the urologist and the medical oncologist need to stay really close in communications with labs because immune-related adverse events can occur at any time and often occur a little bit later. So could they occur postoperatively immediately? Of course they could.

0
💬 0

Comments

There are no comments yet.

Log in to comment.